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Tbx3 promotes liver bud expansion during mouse develop-
ment by suppression of cholangiocyte differentiation.
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Abstract:After speciﬁcation of the hepatic endoderm, mammalian
liver organogenesis progresses through a series of morphological
stages that culminate in the migration of hepatocytes into the under-
lying mesenchyme to populate the hepatic lobes. Here, we show that
in the mouse the transcriptional repressor Tbx3, a member of the
Tbox protein family, is required for the transition from a hepatic
diverticulum with a pseudo-stratiﬁed epithelium to a cell-emergent
liver bud. In Tbx3-deﬁcient embryos, proliferation in the hepatic epi-
thelium is severely reduced, hepatoblasts fail to delaminate, and cho-
langiocyte rather than hepatocyte differentiation occurs. Molecular
analyses suggest that the primary function of Tbx3 is to maintain
expression of hepatocyte transcription factors, including hepatic
nuclear factor 4a (Hnf4a) and CCAAT/enhancer binding protein (C/
EBP), alpha (Cebpa), and to repress expression of cholangiocyte tran-
scriptionfactors such as Onecut1 (Hnf6) and Hnf1b.
Conclusion: Tbx3 controls liver bud expansion by suppressing
cholangiocyte and favoring hepatocyte differentiation in the liver
bud.
 2009 European Association for the Study of the Liver. Published
by Elsevier B.V.
Recently, increased exploration for liver stem/progenitor cells
and the localization of the stem cell niche in the liver has
prompted renewed interest in the factors that regulate expansion
of hepatocytes and cholangiocytes from bipotential hepatoblast
precursor cells during embryonic development. In their publica-
tion in Hepatology, Lüdtke and colleagues examined the role of
Tbx3, a member of the T-box protein family, in the regulation
of liver bud expansion during mouse development [1. The time
frame for the segregation of hepatobiliary lineages has not been
accurately determined especially for cholangiocytes since the
mechanisms are poorly understood and biliary fate determina-
tion does not occur in a single developmental phase [2. Of partic-
ular importance, this manuscript begins to address the
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T-box genes were originally described by geneticists in 1927
with the discovery of a mutation, Brachyury, (or T, for short tail),
which results in a short tail phenotype in mice [3]. The T gene
required in mesoderm formation was cloned in 1990 [4]. T-box
genes participate in the regulation of diverse functions in devel-
opment and mutations in T-box genes have been linked to a
number of human disorders and diseases [5]. T-box genes have
been extensively studied during cardiac development, which is
regulated by multiple T-box genes in a complex mechanism
exhibiting temporal and spatial regulation of the developing
heart [6]. Recent evidence from Suzuki and colleagues has pro-
vided support for the involvement of Tbx3 in hepatogenesis [7].
They demonstrated that Tbx3 is expressed by multipotent hepatic
progenitor cells that were isolated from developing mouse liver
[7]. The deletion of Tbx3 also resulted in the increased expression
of the tumor suppressor gene p19ARF (Cdkn2a), which promoted
growth arrest in hepatoblasts and initiated cholangiocyte differ-
entiation [7].
In their recent publication, Lüdtke and colleagues deﬁnitively
demonstrate that Tbx3 promotes liver bud expansion in Tbx3
mutant mice [1]. The authors demonstrate that Tbx3 is strongly
expressed in the liver bud during the expansion of the phase
[1]. In the Tbx3-deﬁcient embryos, the expansion of the hepatic
epithelium was characterized by a reduction in the expression
of the hepatoblast marker gene alpha fetoprotein and the hepato-
cyte marker albumin. However, there was an increased expres-
sion of the cholangiocyte-speciﬁc marker CK19 in 10–20% of
the cells in the hypoplastic mutant livers [1]. These data indicate
that lack of Tbx3 altered the lineage decision in hepatoblasts and
shifted cell fate towards cholangiocytes at the expense of hepato-
cytes. In contrast to the ﬁndings of Suzuki, et al., there was no
apparent involvement of cell-cycle regulators such as p19ARF in
Tbx3 mutant mice [1]. Tbx3 seems to regulate hepatic develop-
ment by suppressing cholangiocyte differentiation at E9.5 [1].
Interestingly, in addition to its role in cell fate determination,
Tbx3 plays a crucial role in hepatoblast migration, which it most
likely regulates through the expression of prospero-related
homeobox 1 (Prox-1) [1]. At the molecular level, the data pre-
sented suggest that the primary role of Tbx3 is to maintain the
expression of hepatocyte transcription factors (such as hepatic
nuclear factor 4a (Hnf4a) and CCAAT/enhancer binding protein
(C/EBP) and to repress the expression of cholangiocyte differenti-
ation transcription factors (such as, Onecut1 (Hnf6) and Hnf1b)
[1]. The exact mechanisms for the maintenance of hepatocyte10 vol. 52 j 450–451
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transcription factors and repression of cholangiocyte transcrip-
tion factors still need to be elucidated. Since Tbx3 is a transcrip-
tional repressor, the maintenance of hepatocyte differentiation
factors would require a mediator of some sort, while functioning
to repress cholangiocyte transcription factors ﬁts well with the
role of Tbx3 in other systems [8]. Future studies will be required
to elucidate this intricate temporal-spatial pattern of Tbx3 that
occurs in embryonic liver development.
Lüdtke and colleagues also bring to the forefront the potential
role that Tbx3 plays in liver regeneration and disease pathogen-
esis. In particular, one would postulate that Tbx3 plays a beneﬁ-
cial role in the regulation of hepatocyte regeneration following
surgical resection and in response to hepatocellular damage.
However, aberrant expression of Tbx3 in hepatocytes may impact
carcinogenesis. In fact, Tbx3 and the closely related Tbx2 are
over-expressed in several cancers including ovarian, breast, pan-
creatic, cervical, and melanoma cancers. In melanoma, over-
expression of Tbx2 and Tbx3 leads to the down-regulation of E-
cadherin expression and enhances cell migration along with the
inhibition of senescence through the repression of p21CIP1 [9].
In mouse and human liver samples and cell lines, Tbx3was impli-
cated as a gene downstream of the Wnt/b-catenin pathway [10].
The over-expression of Tbx3 in hepatocellular carcinomas and
hepatoblastomas was associated with the mutational status of
b-catenin [10]. In fact, hepatoblastomas with marked over-
expression of Tbx3 were resistant to chemotherapy and linked
to unfavorable patient outcome [10]. To date, no studies have
addressed the potential role of Tbx3 over-expression in cholangi-
ocarcinoma. Expression of Tbx3 in cholangiocarcinoma may
result in the alteration of the differentiation status of the cells,
potentially maintaining to a minimum the de-differentiation of
cholangiocytes towards a hepatocyte phenotype. Many questions
about the regulatory mechanisms of Tbx3 during liver develop-Journal of Hepatology 201ment and regeneration, as well as their potential involvement
in liver cancer remain to be addressed in future studies. The elu-
cidation of the fundamental mechanisms that regulate liver
development is critical for understanding key concepts such as
regeneration following surgical resection, disease processes and
potentially the neoplastic transformation of hepatocytes and
cholangiocytes.
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